Evidence map›Paper›PMID 37720173›Full record

ArticleInternational journal of general medicine2023

Juanzi Zeng, Wenwei Fan, Jiaquan Li, Guowu Wu, Heming Wu

Abstract read
In one paragraph

Article in International journal of general medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Colorectal cancer tumor phenotypes associated withWorld journal of gastrointestinal pathophysiology · 2025
    Article
  5. Article
  6. Article
  7. Molecular identification ofMolecular biology research communications · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Focus onCancers · 2024
    Article
  13. Article
  14. International journal of general medicine · 2024
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Juanzi ZengDepartment of Medical Oncology, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China.
Wenwei FanDepartment of Gastroenterology, Dongguan Eighth People's Hospital, Dongguan, People's Republic of China.
Jiaquan LiDepartment of Medical Oncology, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China.
Guowu WuDepartment of Medical Oncology, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China.
Heming WuCenter for Precision Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China.ORCID 0000-0002-1876-9585

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The occurrence, progression, and prognosis of colorectal cancer (CRC) are regulated by EGFR-mediated signaling pathways. However, the relationship between the core genes ( Methods: Patients were genotyped for Results: Four hundred and eight patients (256 men and 152 women) were included in the analysis. At least one mutation in the four genes was detected in 216 (52.9%) patients, while none was detected in 192 (47.1%) patients. Conclusion:

Indexed as

BRAFclinicopathological featurecolorectal cancerKRASNRASPIK3CA

Identifiers

PMID37720173
PMCPMC10503567

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.